AMERIPRISE FINANCIAL INC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$478,350
-25.8%
356,978
-0.9%
0.00%
Q2 2023$644,661
-35.7%
360,145
+39.7%
0.00%
Q1 2023$1,003,059
+79.1%
257,856
+56.3%
0.00%
Q4 2022$560,000
-39.7%
164,989
-3.0%
0.00%
Q3 2022$929,000
-17.6%
170,029
+93.5%
0.00%
-100.0%
Q1 2017$1,128,000
+112700.0%
87,885
+439325.0%
0.00%
Q3 2014$1,000
-99.9%
20
-99.9%
0.00%
-100.0%
Q1 2014$845,00027,3690.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders